FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / NY ARCA BIOTECH
Shares, excl. options Q1 2024
3.09 M
Holdings value Q1 2024
$475 M
Value change Q1 2024
-$29.8 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
229
Number of buys Q1 2024
73
Number of sells Q1 2024
-118
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
33733E203
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 3.09 M $475 M -$29.8 M $153.77 229
2023 Q4 3.31 M $522 M -$107 M $158.06 249
2023 Q3 4.18 M $612 M -$63.9 M $146.35 235
2023 Q2 4.61 M $706 M -$20.4 M $153.14 244
2023 Q1 4.69 M $727 M -$18.4 M $155.03 237
2022 Q4 4.81 M $742 M +$55.4 M $154.13 232
2022 Q3 4.46 M $589 M +$21.6 M $131.98 204
2022 Q2 4.29 M $582 M -$26.9 M $135.56 208
2022 Q1 4.32 M $645 M -$78.4 M $149.14 205
2021 Q4 4.95 M $801 M -$47.4 M $161.96 235
2021 Q3 5.18 M $860 M -$14.1 M $166.06 229
2021 Q2 5.22 M $900 M -$80.2 M $172.62 224
2021 Q1 5.72 M $918 M -$20.3 M $160.50 224
2020 Q4 5.79 M $974 M -$77.9 M $167.99 224
2020 Q3 6.08 M $956 M -$32.9 M $157.26 204
2020 Q2 6.22 M $1.04 B +$186 M $167.77 217
2020 Q1 4.97 M $653 M -$50.7 M $131.12 183
2019 Q4 4.66 M $694 M -$70.7 M $148.72 197
2019 Q3 5.2 M $644 M -$826 M $123.76 181
2019 Q2 12.5 M $1.76 B +$31.7 M $140.84 210
2019 Q1 12.3 M $1.86 B +$134 M $150.85 218
2018 Q4 11.6 M $1.44 B -$403 M $124.20 188
2018 Q3 14.2 M $2.25 B +$1.43 B $158.49 187
2018 Q2 5.08 M $712 M +$65.2 M $140.01 148
2018 Q1 4.65 M $619 M +$88.5 M $132.90 149
2017 Q4 3.98 M $495 M +$54.5 M $124.57 124
2017 Q3 3.6 M $446 M +$13.8 M $123.93 114
2017 Q2 3.49 M $398 M +$54.6 M $114.04 110
2017 Q1 3.02 M $316 M -$6.54 M $105.30 110
2016 Q4 3.09 M $281 M +$13 M $90.87 106
2016 Q3 2.91 M $289 M -$409 K $99.71 110
2016 Q2 3.08 M $275 M -$39.5 M $89.43 104
2016 Q1 3.32 M $292 M -$1.88 B $87.56 100
2015 Q4 21.7 M $2.46 B +$164 M $113.02 123
2015 Q3 20.1 M $2.04 B +$162 M $101.32 126
2015 Q2 18.4 M $2.29 B +$283 M $124.02 121
2015 Q1 16.1 M $1.91 B +$448 M $118.23 118
2014 Q4 12.3 M $1.26 B +$246 M $102.02 108
2014 Q3 9.63 M $884 M +$85.6 M $91.78 95
2014 Q2 8.69 M $716 M +$32.2 M $82.33 91
2014 Q1 8.32 M $638 M +$51.7 M $76.69 81